Study on Incentives for Glaucoma Medication Adherence (SIGMA): study protocol for a randomized controlled trial to increase glaucoma medication adherence using value pricing.

ABSTRACT:

Background

Many glaucoma patients do not adhere to their medication regimens because they fail to internalize the (health) costs of non-adherence, which may not occur until years or decades later. Behavioural economic theory suggests that adherence rates can be improved by offering patients a near-term benefit. Our proposed strategy is to offer adherence-contingent rebates on medication and check-up costs. This form of value pricing (VP) ensures that rebates are granted only to those most likely to benefit. Moreover, by leveraging loss aversion, rebates are expected to generate a stronger behavioural response than equivalent financial rewards.

Methods/design

The main objective of the Study on Incentives for Glaucoma Medication Adherence (SIGMA) is to test the VP approach rel

SUBMITTER: Bilger M 

PROVIDER: S-EPMC4947326 | biostudies-literature | 2016 Jul

REPOSITORIES: biostudies-literature